Pruitt 2013 Respir Care: Difference between revisions
From Bioblast
(Created page with "{{Publication |title=Pruitt WC (2013) Long-term oxygen therapy: in a perfect world. Respir Care 58:1711-3. doi: 10.4187/respcare.02811 |info=[https://pubmed.ncbi.nlm.nih.gov/2...") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Pruitt WC (2013) Long-term oxygen therapy: in a perfect world. | |title=Pruitt WC (2013) Long-term oxygen therapy: in a perfect world. https://doi.org/10.4187/respcare.02811 | ||
|info=[https://pubmed.ncbi.nlm.nih.gov/24064630/ PMID: 24064630 Open Access] | |info=Respir Care 58:1711-3. [https://pubmed.ncbi.nlm.nih.gov/24064630/ PMID: 24064630 Open Access] | ||
|authors=Pruitt WC | |authors=Pruitt WC | ||
|year=2013 | |year=2013 | ||
Latest revision as of 23:13, 15 July 2022
| Pruitt WC (2013) Long-term oxygen therapy: in a perfect world. https://doi.org/10.4187/respcare.02811 |
» Respir Care 58:1711-3. PMID: 24064630 Open Access
Pruitt WC (2013) Respir Care
Abstract: This issue of Respiratory Care contains 2 papers of interest that deal with long-term oxygen therapy (LTOT). In the first, Martí et al investigated the efficacy of 2 oxygen-conserving devices in correcting exercise-induced hypoxemia in subjects with either COPD or interstitial lung disease (ILD). The next paper, by LeBlanc et al,2 compared the ability of 3 portable oxygen concentrators (POCs) to maintain a satisfactory SpO2 during exercise in subjects with chronic lung disease (18 were diagnosed with COPD, and 3 with pulmonary fibrosis).
• Bioblast editor: Gnaiger E
Labels:
Stress:Hypoxia Organism: Human
MitoFit2022Hypoxia
